Ursodeoxycholic acid (UDCA) is a bile acid produced by the liver to help break down and digest fats and fat-soluble vitamins in the small intestine. UDCA is used to treat gallstones, primary biliary cirrhosis (PBC), and improve itching associated with primary sclerosing cholangitis (PSC). It is prescribed by doctors to dissolve gallstones and helps stimulate bile flow from the liver.

The global ursodeoxycholic acid market is estimated to be valued at US$ 640.45 Mn in 2023 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

The ursodeoxycholic acid market growth is majorly driven by increasing adoption for treatment of liver disorders such as gallstones, PBC and PSC. According to Coherent Market Insights study, prevalence of cholelithiasis or gallstones has been steadily increasing worldwide and found in approximately 10-15% of the adult population in the United States. UDCA plays a crucial role in treatment of gallstones by helping dissolve gallstones and stimulating bile flow from liver. Additionally, growing diagnosis rates of PBC and PSC and limited treatment options further propels the demand for UDCA globally.

As stated above, prevalence of gallstone disease and liver disorders like PBC and PSC have been on rise worldwide. For instance, according to National Institutes of Health, around 100,000 individuals in the United States have been diagnosed with PBC. These rising incidences positively impact the ursodeoxycholic acid adoption and fuel market growth over the forecast period.

SWOT Analysis

Strength: Ursodeoxycholic acid is a proven treatment for liver and gallbladder diseases like primary biliary cholangitis. It helps dissolve cholesterol in bile and improves liver functioning. The drug is approved by many regulatory bodies worldwide and has a well established pharmacological profile. Manufacturers hold several patents that ensure strong market position and profitability.

Weakness: High reliance on animal sources for raw material extraction makes supply susceptible to price fluctuations. Production is centralized in few regions leaving supply vulnerable to disruptions. Generic competition erodes brand loyalty and exerts pricing pressure.

Opportunity: Rising cases of non-alcoholic fatty liver disease (NAFLD) and obesity-related liver diseases expands the patient pool. Emerging economies in Asia Pacific offer huge unmet medical needs. New areas of clinical research may identify additional therapeutic uses augmenting demand.

Threats: Stringent regulations for drug approvals delay market entry of pipeline candidates. Social stigma around animal testing restricts R&D. The complex manufacturing process renders operations vulnerable to quality issues. Substitution threat from alternative treatment options for certain indications.

Key Takeaways

The Global Ursodeoxycholic Acid Market Growth is expected to witness high driven by the increasing prevalence of chronic liver diseases. The global ursodeoxycholic acid market is estimated to be valued at US$ 640.45 Mn in 2023 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030.

Regional analysis related content comprises: The Asia Pacific region is currently the largest as well as the fastest growing market for Ursodeoxycholic acid. This is attributable to factors like the rising incidence of obesity and metabolic disorders, growing health awareness, improving access to diagnosis and treatments, and increasing healthcare spending. China dominates the Asia Pacific ursodeoxycholic acid market with the presence of several domestic manufacturers. India is another high potential market driven by its huge patient population and focus on expanding medical access in rural areas.

Key players related content comprises: Key players operating in the Ursodeoxycholic acid market are Fender Musical Instruments Corporation, Gibson Brands, Ernie Ball Inc., GHS Strings, C. F. Martin & Company Inc., Dunlop Manufacturing, Inc., Dean Markley USA, Inc., Kistron Co., Ltd., Rotosound Manufacturing Ltd., and DR Handmade Strings.

Explore more information on this topic, Please visit -

https://www.pressreleasebulletin.com/ursodeoxycholic-acid-market-share-and-demand-analysis/

Explore more trending article on this topic -

https://diveintoinsights.blogspot.com/2023/12/fastest-growing-segment-fueling-growth_32.html